v
Home About Us Contact Us

 

Table of Content - Volume 4 Issue 1- October 2016


A study of clinico- laboratory profile of the patients with type II diabetes at rural tertiary health care center

 

Mithun Somaiah C S

 

Assistant Professor, Department of General Medicine, BGS Global Institute of Medical Sciences, No. 67, BGS health and Education city Uttarahalli road, Kengeri, Bengaluru, Karnataka- 560060, INDIA.

Email: drmithun.somaiah4899@gmail.com

 

Abstract              Background: The relationship between alteration of serum lipids and vascular complications is more significant in diabetics than in non diabetics amongst the general population. Lipid abnormalities will lead to microvascular and macrovascular diseases in diabetic patients. Aims and Objectives: To Study Clinico- Laboratory profile of the patients with Type II diabetes at Rural tertiary health care center. Methodology: This was a cross-sectional study that was carried out in patients who were admitted to Sri Adichunchanagiri hospital and research center, B.G. Nagara, Mandya attached to Adichunchanagiri Institute of Medical Sciences, B.G. Nagara, Mandya. From the patients admitted, 50 cases with H/O Type 2 diabetes mellitus were taken as subjects for the study. Age and sex matched 50 Non-diabetic were taken as controls. Biochemical analysis was done for Fasting and post prandial blood sugar, Fasting sample for Serum Triglycerides, Total Cholesterol, HDLc, LDLc, VLDLc, The lipid and lipoprotein assay was done using Dr. Lange LP 700 equipment. Statistical Analysis was done by Analysis of variance (ANOVA) continuous scale between two groups Inter group analysis) on metric parameters.. Chi-square/ Fisher Exact test has been used to find the significance of study parameters on categorical scale between two or more groups. Results: Most of the diabetics were in the age group of 60-70. The mean ± SD among the diabetics was 63.48 ± 9.79 and among the control population it was 52.06 ± 7.37. There were 34 males and 16 females among the diabetic population and 33 males and 17 females among the control group. The mean FBS was significantly higher in cases than control i.e. 177.30±41.14 and 94.04±15.15 (<0.001**), The PPBS mg/dl was 310.50±55.78, 139.78±12.78 (<0.001**). Triglycerides and VLDL were significantly raised to the tune of 98% among the diabetics compared to the non diabetics. Total cholesterol was also raised among diabetics compared to the non diabetics. HDL levels were reduced among the diabetics compared to the non diabetics. Triglycerides was 223.54 ± 46.98 among the diabetics compared to 152.26 ± 27.81 among the non-diabetics. VLDL was 45.18 ± 9.72 among the diabetics compared to 30.34 ± 5.59 among non-diabetics. HDL was reduced to 36.24 ± 4.96 among diabetics compared to 41.54 ± 3.46 among non-diabetics. Conclusion: This study laid emphasis on the fact that diabetes mellitus influences lipid metabolism in a significant way. This was evident by the fact that certain lipid fractions such as triglycerides and very low density lipoproteins were elevated and HDL was depressed in diabetics when compared to healthy controls. So hyperlipidemia is quite common in diabetes and hypertriglyceridemia is the most common abnormality.

Key Word: Type II diabetes, Lipid profile, Dyslipidemia, hyperlipidemia, Hyperglycemia.

 

INTRODUCTION

The relationship between alteration of serum lipids and vascular complications is more significant in diabetics than in non diabetics amongst the general population. Lipid abnormalities will lead to microvascular and macrovascular diseases in diabetic patients.1 Lipoprotein abnormalities correlated with large vessel disease are seen in diabetics and non diabetic populations, however atherogenesis is accelerated in diabetics.2,3 Coronary artery disease is among the important vascular complications of diabetes. Diabetes is associated with a marked increase by a factor of two to four times increased risk of coronary artery disease.4 The plasma cholesterol level is a strong predictor of the risk of cardiovascular events both in patients with diabetesand in patients with coronary heart disease5,6 As these groups of patients are at a high risk of morbidity and mortality, the need for more aggressive lipid lowering therapy have been recognized by both the National Cholesterol Education Program7 and American Diabetes Associations8 The risk factors for cardiovascular disease in diabetes include central obesity, hypertension, dyslipidemia, microalbuminuria, coagulation abnormalities, loss of nocturnal dipping of blood pressure and pulse and left ventricular hypertrophy.9 Among the risk factors hypertension is twice as frequent in patients with diabetes as in those without diabetes and accounts for up to 85% of the cardiovascular disease risk. Patients with hypertension are more prone to diabetes than are normotensive persons. In a large population based epidemiologic study with 4400 cohort and using clinical criteria, there was evidence of neuropathy in 7.5% of patients at the time of diagnosis. The prevalence of neuropathy increased to 50% after 25 years of follow up.10 Prospective studies have demonstrated that mean blood pressure levels are significantly higher in those patients who progress to microalbuminuria than in those who do not, indicating that high blood pressure always plays an important role in the pathogenesis of diabetic kidney disease11 but only about 30% develop clinically overt nephropathy. This study reveals some of the evidence relating dyslipidemia to type-2 diabetes mellitus and its vascular complications which were better understood in the last century.

 

MATERIAL AND METHODS

After approval from institutional ethical committee a cross-sectional study was carried out in patients who were admitted to Sri Adichunchanagiri hospital and research center, B.G. Nagara, Mandya attached to Adichunchanagiri Institute of Medical Sciences, B.G. Nagara, Mandya. From the patients admitted, 50 cases with H/O Type 2 diabetes mellitus were taken as subjects for the study. Age and sex matched 50 Non-diabetic were taken as controls. The diagnosis of Diabetes is based on revised criteria according to consensus panel of experts from National Diabetes Data Group and WHO. Patients with Type 2 diabetes mellitus of more than 40 years of age, Duration of Diabetes more than 4 years were included into study while The control group consists of non diabetics more than 40 years, who are normotensive, who do not have concomitant diseases or other conditions or use drugs that affect lipid levels.  Type -2 diabetes patients with concomittant diseases or condition affecting the lipid levels like hypothyroidism, on lipostatic drugs, thiazides etc, Age below 40 years were excluded from the study. A detailed history was taken and careful physical examination done alongside Routine Blood and Urine examination. Biochemical analysis for Fasting and post prandial blood sugar was done, Fasting sample for Serum Triglycerides Total Cholesterol, HDLc, LDLc, VLDLc, The lipid and lipoprotein assay was done using Dr. Lange LP 700 equipment, Total cholesterol-CHOD - DAP method, Total Triglycerides-GPO - DAP method, HDL cholesterol (HDL - C)-Enzymatic estimation, LDL Cholesterol estimation-LDL = Total cholesterol – HDL – Serum Triglyceride/5, VLDL Cholesterol-its concentration can be approximated by dividing the amount of plasma triglycerides by 5 described by Friedewald in 1972. Statistical Analysis done by Descriptive and inferential statistical analysis has been carried out in the present study. Results on continuous measurements are presented on Mean ± SD (Min-Max) and results on categorical measurements are presented in Number (%). Significance is assessed at 5 % level of significance. The following assumptions on data is made, Assumptions: 1.Dependent variables should be normally distributed, 2.Samples drawn from the population should be random, Cases of the samples should be independent. Analysis of variance (ANOVA) has been used to find the significance of study parameters between three or more groups of patients, Student t test ( two tailed, independent) has been used to find the significance of study parameters on a continuous scale between two groups (Inter group analysis) on metric parameters.. Chi-square/ Fisher Exact test has been used to find the significance of study parameters on a categorical scale between two or more groups.

 

RESULTS

 

Table 1: Age distribution of patients studied

Age in years

Cases

Controls

No

%

No

%

40-50

7

14.0

24

48.0

50-60

13

26.0

21

42.0

60-70

25

50.0

5

10.0

70-80

4

8.0

0

0.0

>80

1

2.0

0

0.0

Total

50

100.0

50

100.0

Mean ± SD

63.48±9.79

52.06±7.37

P = <0.001**

Most of the diabetics were in the age group of 60-07 more became it was a random study. The man ± SD among the diabetics was 63.48 ± 9.79 and among the control population it was 52.06 ± 7.37.

Table 2: Gender distribution of patients studied

Gender

Cases

Controls

No

%

No

%

Male

34

68.0

33

66.0

Female

16

32.0

17

34.0

Total

50

100.0

50

100.0

Samples are age matched with P = 1.000

There were 34 males and 16 females among the diabetic population and 33 males and 17 females among the control group.

 

Table 3: Comparison of sugar parameters in two groups of patients studied

Sugar parameters

Cases

Controls

P value

FBS mg/dl

177.30±41.14

94.04±15.15

<0.001**

PPBS mg/dl

310.50±55.78

139.78±12.78

<0.001**

The mean FBS was significantly higher in cases than control i.e. 177.30±41.14 and 94.04±15.15 (<0.001**), The PPBS mg/dl was 310.50±55.78, 139.78±12.78 (<0.001**).

 

Table 4: Distribution of lipid parameters in two groups of patients studied

Lipid parameters

Cases

(n=50)

Controls

(n=50)

P value

No

%

No

%

Total cholesterol mg/dl

 

 

 

 

 

<200

18

36.0

39

78.0

<0.001**

>200

32

64.0

11

22.0

LDL mg/dl

 

 

 

 

 

<130

27

54.0

40

80.0

<0.001**

>130

23

46.0

10

20.0

Triglyceride mg/dl

 

 

 

 

 

<150

1

2.0

27

54.0

<0.001**

>150

49

98.0

23

46.0

HDL mg/dl

 

 

 

 

 

<40

34

64.0

13

26.0

<0.001**

>40

16

32.0

37

74.0

VLDL mg/dl

 

 

 

 

 

<30

1

2.0

26

52.0

<0.001**

>30

49

98.0

24

48.0

Triglycerides and VLDL were significantly raised to the tune of 98% among the diabetics compared to the non diabetics. Total cholesterol was also raised among diabetics compared to the non diabetics.  HDL levels were reduced among the diabetics compared to the non diabetics.

 

Table 5: Comparison of lipid parameters in two groups of patients studied

Lipid parameters

Cases

Controls

P value

Total cholesterol mg/dl

209.02±27.15

180.78±24.21

<0.001**

LDL mg/dl

126.82±25.63

106.80±27.41

<0.001**

Triglyceride mg/dl

223.54±46.98

152.26±27.81

<0.001**

HDL mg/dl

36.24±4.96

41.54±3.46

<0.001**

VLDL mg/dl

45.18±9.72

30.34±5.59

<0.001**

Triglycerides was 223.54 ± 46.98 among the diabetics compared to 152.26 ± 27.81 among the non-diabetics. VLDL was 45.18 ± 9.72 among the diabetics compared to 30.34 ± 5.59 among non-diabetics. HDL was reduced to 36.24 ± 4.96 among diabetics compared to 41.54 ± 3.46 among non-diabetics.

 

DISCUSSION

Diabetes is characterized by chronic hyperglycemia and disturbances of carbohydrate, lipid and protein metabolism12. Dyslipidemia is one of the major risk factor for cardiovascular disease in Type 2 Diabetes mellitus, characterized by elevated Total cholesterol (TC), Triglycerides (TG), Low density lipoprotein (LDL) and decreased High density lipoprotein (HDL) 13. Because detection and treatment of dyslipidemia is one means of reducing Cardiovascular Disease (CVD) risk, determination of serum lipid levels in people with diabetes is now considered a standard of care14.Most of the diabetics under the study group were males (68%) compared to (32%) females which was comparable to Ajagnakar and Sathi et al 1989 and Vaishnava et al 1989 who's s studies implied that the incidence of diabetes was greater among the male population compared to the females. In the study group most of the diabetics were in the age group of 60-70 years, moreso because it was a random study. Dyslipidemia was an obvious feature in the present study among the study group. TG's and VLDL's were significantly raised to the tune of 98% in the study population compared to the control population. HDL levels were reduced among the diabetics when compared to the non diabetics. These findings corroborated with the Study conducted by Mazzone et al( 2000) where he documented an increase in TG's. In this study it was observed that apart from an increase in TG's and VLDL and decrease in HDL, TC also was found to be slightly raised in the study. A study conducted by H.O Otamere et al also documented an increase in triglycerides, total cholesterol, LDL and decrease in HDL which was similar to the findings in this study Studies such as Fredrick et al( 1994), Michel et al( 1987) also documented increased levels of TG's, VLDL and decreased levels of HDL which was pretty much the picture in this study. Chase and Glasgow et al ( 1976) conducted a study and documented elevated levels of TG's, TC, LDL and depressed levels of HDL, similar to that observed in this study P.K. Bijlaani et al (1983) and Barr et al ( 1951)found that HDL levels were depressed in diabetics which was one of the finding in this study as well with mean HDL level of (36.24±4.96) among the diabetic population compared to HDL level of (41.54±3.46) among non diabetics These findings were similar to that of which showed that Elevated LDL-C, elevated TCHOL, elevated TRG, and reduced HDL-C levels were noted in 28.37%, 36.37%, 39.01%, and 30.12% of the patients, respectively 15. Low density lipoprotein and TG were highest among 50-59 years age group while TC was highest among 70-79 years in both male and female participants. HDL was lowest among 60-69 years male and 40-49 years female. A similar study showed that Median and upper range of total cholesterol, HDL-C and LDL-C were found to be higher in women than in men in all the age groups. However triacylglycerol and VLDL-C concentrations were observed to be higher in the men than women except in age group of 61-70 years 16.

 

CONCLUSION

This study laid emphasis on the fact that diabetes mellitus influences lipid metabolism in a significant way. This was evident by the fact that certain lipid fractions such as triglycerides and very low density lipoproteins were elevated and HDL was depressed in diabetics when compared to healthy controls. So hyperlipidemia/dyslipidemia is quite common in diabetes and hypertriglyceridemia is the most common abnormality.

 

REFERENCES

  1. Chaturvedi N, John H. Fuller and Marja-RittaTaskinen. Differiassociations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes. Diabetes care 2001; 24 (12) : 2071-207
  2. Mazzone T. Current concepts and controversies in the pathogenesis, prevention and treatment of the macrovascular complications of diabetes. J Lab Clin. Med. 2000; 135: 437 – 443.
  3. Pyörälä K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: An Epidemiologic view. Diabetes Metab Rev 1987; 3:463-524.
  4. Rosengren A, Welin L, Tsipogianni A, Wilhelmsen L. Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study. BMJ 1989; 299: 1127-1131.
  5. Pekkanen J, Linn S, Heiss G. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without pre-existing cardiovascular disease. N Engl J Med 1990; 322: 1700-1707.
  6. Rosengren A, Hagman M, Wedel H, Wilhelmsen L. Serum cholesterol and long-term prognosis in middle-aged men with myocardial infarction and angina pectoris: a 16-year follow-up of the Primary Prevention Study in Göteborg, Sweden. Eur Heart J 1997; 18: 754-761.
  7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993; 209: 3015-3023.
  8. American Diabetes Association. Management of dyslipidemia in adults with diabetes. Diabetes Care 1998; 21: 179-182.
  9. Sowers JR, Epstein M, Frohlic ED. Diabetes, hypertension and cardiovascular diseases and update. Hypertension 2001; 37: 1053-1059.
  10. Pirat J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947-1973. Diabetes Metab 1977; 3.
  11. The micro albuminuria collaborative study group. Predictions of the development of microalbuminuria in patients with type 1 diabetes mellitus: a seven year prospective study. Diabetes 1999; 16: 918-925.
  12. Ozder A (2014) Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: A cross-sectional study. Lipids Health Dis 13: 183.
  13. Reddy AS, Meera S, William E, Kumar JS (2014) Correlation between glycemic control and lipid profile in type 2 diabetic patients: HbA1c as an indirect indicator of dyslipidemia. Asian J Pharm Clin Res 7: 153-155.
  14. Kayode JA, Adediran OS, Agboola S, Adebisi SA, Idowu A, et al. (2010) Lipid profile of type 2 diabetic patients at a rural tertiary hospital in Nigeria. J Diabetes Endocrinol 1: 46-51.
  15. Stamouli M, Pouliakis A, Mourtzikou A, Skliris A, Panagiotou I, et al. (2014) Evaluation of the lipid profile in type 2 diabetes mellitus patients in Greece. Clin Lab 60: 1593-600.
  16. Das M, Saikia M (2009) Estimation of reference interval of lipid profile in assamese population. Indian J ClinBiochem 24: 190-193.

 


 


 

 

 

 

 

 

 

 

Policy for Articles with Open Access
Authors who publish with MedPulse International Journal of Anesthesiology (Print ISSN:2579-0900) (Online ISSN: 2636-4654) agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.